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ABSTRACT 
Transmissible spongiform encephalopathies (TSE) are a group of infectious 
diseases caused by a misfolded protein. Naturally occurring TSEs are found in numerous 
species including sheep, cattle, and mink. The naturally occurring TSE of sheep is called 
scrapie. Scrapie is one of the oldest described TSEs, and it is caused by a misfolded 
protein (PrPSc) that initiates an autocatalytic conversion of an endogenous host protein 
(PrPC). The mammalian PRNP gene encodes PrPC, and sheep are variably susceptible to 
disease based on naturally occurring polymorphisms in the PRNP gene at codons 136, 
154, and 171. The selection of resistant genotypes is essential to scrapie eradication 
programs. Currently there are polymorphisms in some breeds of sheep that have not been 
thoroughly investigated vis-à-vis their contribution to scrapie susceptibility. Herein we 
describe the contribution of lysine at codon 171 (K171) of the PRNP gene towards 
resistance to classical scrapie. Using sheep, the natural host, as model to evaluate genetic 
susceptibility, we experimentally infected sheep with different allelic polymorphisms at 
codon 171. Orally inoculated sheep with the homozygous lysine 171 (KK171) genotype 
did not develop scrapie or harbor any detectable PrPSc. In the second study encompassing 
this work, we sought to evaluate the etiology of transmissible mink encephalopathy 
(TME), a naturally occurring TSE of mink. TME is a foodborne TSE of farmed mink, 
and earlier theories suggested that classical scrapie or atypical BSE may have been the 
source of prions to mink. The etiology of prion diseases is best understood by 
experimental transmission between species. To determine if scrapie is the source of TME, 
we examined the susceptibility and disease phenotype of sheep inoculated with the TME 
agent. We determined that only intracranially inoculated sheep are susceptible, and the 
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disease phenotype in sheep is different from classical scrapie. Primarily, sheep inoculated 
with the TME agent do not develop immunoreactivity for PrPSc in their lymphoid tissue; 
whereas, it is known that sheep with classical scrapie have prominent lymphoid 
accumulation of PrPSc. Cumulatively, this research expands the current knowledge of 
ovine genetic susceptibility to scrapie and indicates that classical scrapie is not likely to 
be the source of TME. Practically, the knowledge presented in this work is immediately 




 GENERAL INTRODUCTION AND LITERATURE REVIEW 
Dissertation Organization 
This dissertation is arranged in the alternative journal paper format, and it is divided 
into three manuscripts. In this first chapter, a detailed review of relevant scientific literature 
is presented. The literature review was prepared for submission as a review for the American 
Journal of Veterinary Research. The second chapter was published as an infectious disease-
original research article in the journal Veterinary Pathology. The third chapter was prepared 
for submission as an original research paper to Frontiers in Veterinary Science. The figures 
and tables cited within the text appear at the end of their respective chapters.  
 
Literature Review 
The pathogenesis, detection, and control of scrapie in sheep 
Modified from a review prepared for submission to the 
American Journal of Veterinary Research 
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Service, United States Department of Agriculture, Ames, IA, USA  
bOak Ridge Institute for Science and Education (ORISE) through an interagency agreement 
between the U.S. Department of Energy and the U.S. Department of Agriculture  
 
Abstract 
Sheep scrapie is a fatal neurologic disease that is caused by an infectious misfolded 
protein called a prion. The prion protein is encoded by an endogenous gene, PRNP, and it 
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resides in high concentrations within the central nervous system. A broad range of functions 
for the prion protein have been uncovered, but the entire range of function is undetermined. 
In the misfolded conformation, prion accumulation results in neurodegeneration. There are 
several naturally occurring polymorphisms in the PRNP gene, and there is a strong 
correlation between disease susceptibility and the PRNP genotype. The cornerstone of many 
scrapie eradication programs is selection of scrapie resistant genotypes. The transmission of 
scrapie often occurs between sheep in the periparturient period when lambs are the most 
susceptible due to higher densities of gut-associated lymphoid tissue. Subsequently, prions 
are disseminated to the lymphoid system and spread to the central nervous system. The 
shedding of prions occurs prior to the onset of clinical signs. In contrast to classical scrapie, 
atypical scrapie is a spontaneous form of scrapie that occurs in individual older animals 
within a flock. It is not considered to be naturally infectious. This review outlines the current 
modalities for diagnosing scrapie in sheep and the techniques for studying its host range and 
pathogenesis. Scrapie transmission to other species including deer has been demonstrated 
experimentally as well as the transmission of non-scrapie prion diseases to sheep. Finally, the 
effectiveness of the United States scrapie eradication program is reviewed. 
 
Background 
The History of Prion Diseases and the Protein Only Theory 
Transmissible spongiform encephalopathies (TSEs) are protein misfolding diseases 
that lead to fatal neurodegeneration.1 The misfolded protein, denoted PrPSc, is derived from 
the endogenous cellular prion protein, PrPC.2 There are many naturally occurring prion 
diseases of animals and humans: scrapie in sheep and goats,3 kuru4,5 and Creutzfeldt-Jakob 
disease in humans,6 bovine spongiform encephalopathy in cattle,7,8 chronic wasting disease 
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in cervids,9,10 feline spongiform encephalopathy in cats,11 transmissible mink encephalopathy 
in mink,12,13 and, recently described, camel prion disease in dromedary camels.14 Scrapie is 
the oldest recorded prion disease; references to scrapie date back at least 300 years.15 In 18th 
century England during the agricultural and textile revolution, scrapie was a politico-
economic concern. The disease was even discussed in the British House of Commons in 
1775 due to mounting concerns about the potential economic effects on the merchant trade of 
woolen products.16 There are also well-described clinical signs of scrapie that appear in a 
German text from the same time period.17 However, it wasn’t until the end of the 19th century 
that the archetypal pathologic vacuolation (spongiform encephalopathy) was first 
documented.18 
Initial attempts at experimental transmission of scrapie did not yield positive results, 
because insufficient time was allowed for incubation. The first successful transmission was 
published in the 1930’s after animals were observed for a prolonged period after 
inoculation.19 Even with successful demonstration of transmissibility, the etiologic agent of 
scrapie was still unknown; however, the experiments suggested that the agent of scrapie was 
not a “typical” pathogen. Ionizing radiation, extreme heat, and chemicals known to 
deactivate viruses and bacteria failed to inactive the agent of scrapie.20-22 This was the first 
step towards a “protein only” theory. In 1967, J.S. Griffith overtly proposed that a protein, 
and not an organism containing nucleic acid, was the etiologic agent of scrapie.23 Suitable to 
the central dogma of biology, he posed several hypotheses by which a protein could be the 
scrapie agent. In one, he correctly speculated that “the protein” could be one that the animal 
was “genetically equipped to make, but not in that [deleterious] form”. Such a gene was first 
described by Dickinson and colleagues in 1968. By back crossing F1 progeny with their 
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donor parent, they demonstrated an autosomal gene without dominance that was linked to the 
duration of scrapie incubation in mice.24 The gene was aptly named “sinc” for “scrapie 
incubation”. Within a decade-and-a-half of J.S Griffith’s published hypotheses, Stanley 
Prusiner coined the term “prion” (pronounced pree-on) in his preeminent manuscript 
outlining his hypotheses on the etiology of scrapie.1 The most revolutionary concept was a 
protein-only theory that advocated the existence of an infectious protein. Since purification 
of the scrapie agent had not been accomplished yet, he also cautiously proposed that nucleic 
acid might exist undetected within the core of a tightly packed resilient protein coat. Later in 
the same year, Prusiner, Boulton, and colleagues isolated and purified scrapie prions.25 The 
protein isolated was approximately 27,000 to 30,000 daltons, and as such, was often referred 
to as PrP27-30 in early studies. PrP27-30 is the main component of the PK-resistant core of 
PrPSc.26 
Hoping to identify viral mRNA in scrapie infected brains, Chesebro et al.27 designed 
an oligonucleotide probe corresponding to the translated mRNA sequence of PrP27-30. 
Using the probe, a cDNA clone was obtained from scrapie infected brain. The isolated 
sequence correctly translated back to the amino acid sequence of PrP27-30. Concurrently, the 
researchers also derived the same sequence from normal control mice and hamsters, 
indicating that PrP27-30 was most likely derived from an endogenous gene. Other work was 
performed contemporarily that reported similar findings.28 In addition to mice and hamsters, 
humans were also found to have a gene encoding PrP27-30 (PRNP). PrP27-30 was detected 
in both scrapie infected and normal animals, but the detection of the protein from normal 
brains was lost after the application of proteinase K (PK). The protein only theory was given 
ever-increasing credibility after susceptibility to scrapie was eliminated in PrP-/- mice.29 
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Further convincing evidence was added by the creation of de novo infectious prions 
recombinantly expressed in E. coli.30,31 These recombinant de novo prions that exhibited 
attributes of pathogenic PrPSc were used to effectively reproduce disease in mice. Taken 
together, these data provide overwhelming evidence that prion infectivity and disease is 
related to conformational alterations in the host’s prion protein.  
 
Normal Cellular Prion Protein (PrPC) 
The cellular prion protein (PrPC) is a glycoprotein approximately 231 amino acid 
residues long32 that is fixed to the cell’s plasma membrane via phosphatidylinositol, a 
glycolipid anchor.33 There are well-conserved octapeptide repeats that bind Cu2+ in the NH2-
terminus.34 In sheep, PRNP mRNA transcripts are found at the highest levels in the thalamus 
and cerebrum followed by the cerebellum, spinal cord, spleen, other lymphoid tissues, brain 
stem, gastrointestinal tract, and reproductive organs.35  
Many functions of PrPC have been elucidated, but the entire range of functions is not 
known. A prion gene knockout in mice is sublethal, and there are no obvious phenotypic 
changes.36 However, there is a broad range of testable phenotypic changes that indicate that 
the activity of PrPC is diverse. For example, PrPC deficient mice have abnormal spatial 
cognitive abilities that are rescuable by reintroduction of PrPC to neurons.37 Other 
physiologic roles of PrPC include synaptic function,38 murine uterine decidualization,39 and 
sleep regulation.40 Physiologic activities of PrPC in the immune system include host-pathogen 
interactions,41-43 T cell to dendritic cell immunosynapse formation,44 and negative regulation 
of phagocytosis.45 There also appear to be important neuroprotective functions of PrPC that 
are related to its binding capabilities. A fragment of the N-terminal portion of PrPC is capable 
of binding to neurotoxic β-amyloid oligomers thereby abating their deleterious effects.46,47 
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Other protective effects are exerted by reducing free radical damage to neurons. The prion 
protein decreases oxidative damage by affecting superoxide dismutase activity.48-51 
Additionally, by binding Cu2+,52 PrPC abates hydroxyl radical (OH•) creation by preventing 
free Cu2+ from participating in the Fenton reaction. Given the role of free Cu2+ in the creation 
of reactive oxygen species, the association of high concentrations of PrPC around the 
neuronal synapse,53 where copper is also released,54 is not surprising. In fact, the response of 




Prion Protein Structure and Misfolding 
 Prion diseases result from the accumulation of a misfolded form of the normal 
cellular prion protein.2 The cellular prion protein and the scrapie prion have distinct structural 
characteristics evident in their secondary and tertiary structures. PrPC is comprised of 40% α-
helical and 3% β-helical folds; however, PrPSc is folded into a parallel left-handed β-helical 
structure containing a 30% α-helical and 40% β-helical conformation.55,56 Individual β-sheets 
organize to form a helical pattern that is purported to associate in a three or four-rung β-
solenoid that polymerizes into amyloid fibrils.57,58 There are at least two proposed models for 
PrPSc autocatalytic propagation (reviewed by Aguzzi and colleagues).59 The refolding model 
assumes that an initial conversion event is precluded by an energy barrier; however, once 
PrPSc is introduced or the energy barrier to conversion is breached, transformation of PrPC 
into PrPSc ensues. Another model called the “seeding model” asserts that PrPSc and PrPC exist 
in thermodynamic equilibrium between the two forms. In this model, PrPSc begins to 
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aggregate when a highly ordered monomeric PrPSc, the seed, stabilizes and recruits more 
monomeric PrPSc to form larger aggregates.  
Aggregation of misfolded proteins in the brain is a pathologic feature of prion 
disease, but exactly how prion disease results in neurodegeneration is less clear. Direct 
neurotoxicity, indirect toxicity, dysregulation of the unfolded protein response (UPR), and 
loss of the normal neuroprotective functions of PrPC are hypothesized mechanisms that 
trigger neurodegeneration. Direct toxicity of PrPSc to neurons is likely refuted by the lack of 
neuronal pathology in PrPC depleted mice inoculated with PrPSc.60,61 On the other hand, there 
is evidence that indirect toxicity and dysregulation of the cellular UPR provoke 
neurodegenerative changes.62-65 Interestingly, the prototypical vacuolar change associated 
with spongiform encephalopathies is not a prerequisite to clinical neurologic signs.66 
 
Transmission and Pathogenesis of Scrapie in Sheep 
The main route of transmission in naturally occurring classical scrapie is through the 
oral route,67 and exposure at birth seems to be a major risk factor in developing disease. 
Contact with infected fetal membranes in the periparturient period or contamination of the 
environment by this material contributes to transmission.68,69 Nursing lambs can also be 
exposed to PrPSc through colostrum and milk.70,71 After birth, environmental contamination 
serves as a reservoir for infectious PrPSc resulting in horizontal transmission of scrapie.72 In 
addition to reproductive tract-associated shedding, PrPSc is shed in the saliva,73,74 urine,75,76 
and feces77 of infected sheep. Shedding during the preclinical stage of disease78 is of 
particular concern for the transmission of scrapie. Additionally, both PK resistant and PK 
susceptible conformers of PrPSc are known to be infectious.79 
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The pathogenesis of natural scrapie infection can be separated in three phases: GALT 
invasion, lymphatic invasion and spread, and neuroinvasion.66,80 After oral exposure, PrPSc 
crosses the mucosal border at the palatine tonsil, distal jejunum, and ileum. In the small 
intestine PrPSc accumulates in Peyer’s patches,81 and M cells are a critical entry point for 
PrPSc.82 After entry, the movement of prions from M cells to the Peyer’s patch is facilitated 
by conventional dendritic cells expressing the chemokine receptor CXCR5.83 The presence of 
prions within the Peyer’s patches is essential for disease development,84 and there is initial 
replication of PrPSc in the follicular dendritic cells (FDCs) that express PrPC.85 FDC deficient 
models indicate that there is a marked decrease in susceptibility to scrapie infection; 
however, FDC-independent pathways of neuroinvasion also appear to exist.86-88  
During the asymptomatic incubation period, PrPSc disseminates throughout the 
lymphoid system.66,81 The spread of PrPSc from the palatine tonsil and Peyer’s patches to the 
medial retropharyngeal and mesenteric lymph nodes occurs through afferent drainage of 
lymph. It is less clear how PrPSc accumulates in other organs like the spleen that does not 
receive afferent lymphatic drainage, but hematogenous spread is a likely route. 
Hematogenous spread of PrPSc is supported by observations of early neuroinvasion to the 
circumventricular organs that lack a blood-brain barrier.89 Furthermore, hematogenous 
dissemination is supported by research that demonstrates infectious prions in the blood of 
sheep.90-93  
The initial site of neuroinvasion is the enteric nervous system (ENS). In an 
experimental sheep scrapie model, invasion of the ENS did not occur until after widespread 
PrPSc lymphoid dissemination.66 Infection of ENS neurons could occur at multiple levels. 
The first possibility is through submucosal fine nerve fibers in close proximity to mucosal 
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epithelium and lacteals.94 Alternatively, active cell transport or drainage of PrPSc from 
Peyer’s patches to the ENS could occur.95 The latter is supported by studies documenting the 
preferential accumulation of PrPSc in the ENS adjacent to Peyer’s patches.81,96 After entering 
the ENS, PrPSc moves retrograde along efferent axons of parasympathetic and sympathetic 
neurons to the medulla oblongata or the thoracic spinal cord, respectively.80  
In cases of natural infection, PrPSc does not stimulate a humoral response owing to the 
identical amino acid sequences of PrPC and PrPSc.97,98 Since T-cells process antigen as linear 
epitopes, they cannot discriminate between peptide sequences of PrPSc and PrPC; therefore, 
antigen presenting cells are deprived of necessary T-cell costimulatory signals required to 
elicit robust humoral immunity. There is evidence that complement components interact with 
PrPSc, and membrane attack complexes localize in scrapie infected brains.99-101 These 
mechanisms proposedly contribute to neurodegeneration. Additionally, complement 
meditated endocytosis may contribute to the movement of PrPSc to lymphoid tissues by 
dendritic cells expressing CD35 (complement receptor 1).102 
 
Determinants of Susceptibility and Resistance of Sheep to the Scrapie Agent 
 Susceptibility to the classical scrapie agent is determined by the host PrP genotype, 
exposure age, volume of infectious dose, and route of infection. In sheep there are several 
naturally occurring polymorphisms in the prion gene. There are three main sites or codons 
that have the greatest impact on susceptibility: 136, 154, and 171.103-111 Valine at codon 136 
(V136), arginine at 154 (R154), and glutamine at 171 (Q171) are associated with 
susceptibility to scrapie. Conversely, the following amino acid polymorphisms confer 
relative resistance: alanine (A136), histidine (H154), and arginine (R171). The polymorphic 
codons 136 and 171 appear to have a greater effect than codon 154 on ultimate disease 
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vulnerability.107,112 A lysine (K) amino acid substitution at codon 171 is seen in Dorper, 
Barbados, Barbados/St Croix, Suffolk crosses, and some Mediterranean breeds.113-115 
Epidemiologic studies reveal that sheep carrying this allele are infrequently scrapie positive 
in natural settings.114 Experimentally, heterozygous QK171 genotype sheep have prolonged 
incubation periods after intracerebral inoculation.116 The relative resistance in decreasing 
order of common PrP genotypes observed in natural scrapie cases is ARR/ARR > ARR/ARQ 
> ARQ/ARQ > ARR/VRQ > ARQ/VRQ > VRQ/VRQ.117 While the ARR/ARR genotype is 
highly resistant to scrapie, there are at least three cases of naturally occurring scrapie in 
homozygous ARR sheep documented around the world.118,119  
The age at first exposure affects susceptibility to scrapie. Statistical modeling from a 
large flock indicated that sheep younger than 24-months-old at the time of exposure had three 
times the risk for developing scrapie compared to older sheep.120 Since Peyer’s patches are 
required for lymphoreticular uptake of scrapie in the intestine,84 the age related effect on 
susceptibility is likely due to decreasing GALT density. The percentage of ileal Peyer’s 
patches averages 49.8-60.3% in 0-3 month-old lambs; in sheep older than 18 months, the 
average percentage of ileal Peyer’s patches is 0-7%.121 As previously described, FDC are 
also associated with early scrapie pathogenesis. An age-related decrease in the FDC network 
within Peyer’s patches also occurs.122 Together these findings offer a compelling explanation 
for the observed age-related susceptibility phenomenon.  
 
Strains of the Scrapie Agent 
The concept of prion strains refers to the distinct pathologic characteristics conferred 
by different isolates of a TSE agent. Dissimilar strains can result in observable differences in 
attack rates, incubation periods, clinical signs, brain vacuolation, molecular patterns, and 
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immunolabeling patterns.123-125 A widely utilized and accepted method for differentiating 
TSE strains is by comparing the degree of brain vacuolation and the incubation periods in 
inbred mice.126-128 PrPSc immunolabeling patterns (PrPSc profiling) can be used to 
differentiate strains of scrapie in sheep without passage in mice.125,129,130  
In the United States, different strains of scrapie have been identified from natural 
field cases. Field isolates 13-7 and x124 are recognized as separate strains based on 
differences in their PrPSc immunolabeling profiles in sheep and attack rates in C57BL/6 
mice.131 Worldwide, strain typing techniques in inbred mice have identified at least 15 
distinct strains of classical scrapie.132 There are also at least three distinct PrP glycoform 
types documented for classical scrapie isolates from archival scrapie samples in the UK.133 In 
one manuscript, these glycoform types were separated into distinct categories, A, B, and C, 
based on their relative mobilities and glycoform ratios observed by western blotting. 
Glycoform type A was derived from experimental and natural cases of scrapie, and type B 
was observed only from natural cases. The observed differences between glycoforms A and 
B from scrapie cases provides evidence that there are naturally occurring scrapie strains. The 
type C glycoform was an experimental isolate named CH1641; it is similar to the glycoform 
signature of C-BSE in sheep.133,134 However, despite their biochemical similarity, C-BSE and 
CH1641 scrapie are distinguishable upon transmission to mice. This suggests that 
biochemical analysis should be used in conjunction with other methods to distinguish strain 
characteristics.  
There are multiple theories for how different strains arise in a host. Two recognized 
theories are the “cloud hypothesis” and the “deformed template theory”. According to the 
cloud hypothesis, isolates are comprised of a heterogeneous mixture of PrPSc conformations 
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(strains), and over time a permissive conformer arises to become the predominant 
variant.135,136 Prevailing conformers are host selected by differences in the replication 
environment. This varies from the deformed template theory that assumes there is initially a 
predominant conformer instead of a mixture.137 After changes in the environment, trial and 
error seeding events generate a new dominant conformer. It is hypothesized that this 
difference in transmissibility can be accounted for by the existence of multiple conformers 
(strains) within an isolate.138-140 These models require that each conformer has a distinct 




In 1998 a novel type of scrapie called Nor98 or atypical scrapie was identified in 
sheep.141 Atypical scrapie differs from classical scrapie since it is considered a spontaneously 
occurring prion disease that typically occurs in a single older animal within a flock.142 The 
distribution of brain lesions is also distinct in atypical scrapie. Vacuolation and PrPSc occurs 
in the cortex of the cerebellum and cerebrum;141,143 whereas, in classical scrapie, lesions are 
concentrated in the medulla oblongata, especially the dorsal motor nucleus of the vagus 
nerve. Another prominent difference is that atypical scrapie does not result in detectable 
lymphoid accumulation of PrPSc. Interestingly, cases of experimental atypical scrapie with 
undetectable PrPSc by immunoassay were found to contain infectious PrPSc in lymphoid 
tissue, muscles, and peripheral nervous tissue.144 These results were determined by positive 
bioassays in transgenic mice expressing sheep prion protein. The next section discusses the 
use of laboratory techniques including mouse bioassays for studying prion diseases.  
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Diagnostic and Research Methods for Studying the Scrapie Agent  
The current standard for identifying PrPSc utilizes anti-PrP antibodies. Many 
antibodies are available and recognize different conformational or linear epitopes of PrPSc. 
Typically, antibodies are generated by injecting a PrP-/- animal with PrPC followed by 
selecting neutralizing antibodies. The use of anti-PrP antibodies can be applied to various 
immunoassay techniques including western blot (WB or immunoblot), enzyme-linked 
immunoassay (ELISA), immunohistochemistry (IHC), immunocytochemistry and 
immunoprecipitation. Usually digestion with PK is a necessary step for antibody 
discrimination between PrPC and PrPSc. After PK digestion, PrPC is undetectable, and the 
resistant core of PrPSc (PrP27-30) remains intact for immunodetection.26 Owing to the 
recognition of unique conformational epitopes, there are some antibodies that selectively 
bind PrPSc without first digesting PrPC with PK.145 
Accumulation of PrPSc in the brain is detectable with IHC after death; however, PrPSc 
is also detectable in the lymphoid tissue of a high number of scrapie affected animals (98%) 
that have neuropathological changes.146 Antemortem diagnostics to detect preclinical scrapie 
utilize immunohistochemistry on lymphoid tissue samples including tonsils,147 third eyelid 
mucosa,148 and recto-anal mucosa.149 The acquisition of tonsillar biopsies in live animals 
requires a honed skillset and may require anesthesia. Given this difficulty, a more accessible 
biopsy site from the third eyelid conjunctiva that utilizes local analgesia was developed as an 
antemortem test. Biopsy of the third eyelid reportedly yields a minimum number of lymphoid 
follicles in roughly 80% of samples that corresponds to an estimated test sensitivity of 85-
90%.150 A drawback of the eyelid biopsy technique is that older animals tend to have less 
third eyelid lymphoid tissue. Furthermore, lymphoid tissue does not regenerate at this 
location precluding repeated sampling.150 Considering the number of lymphoid follicles per 
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biopsy, rectal mucosa is superior to both tonsil and third eyelid conjunctiva.149 Another 
advantage of rectal mucosa biopsies is that this site can be biopsied multiple times without a 
decrease in the number of follicles obtained, and anesthesia or sedation is not required. For 
comparison to other methods, 87% of rectal biopsies had at least 10 follicles present, which 
corresponded to a false negative rate of about 9%. In addition to the use of IHC, rectal 
mucosa biopsies can be used in tandem with enzyme immunoassay.151 Negative test results to 
any antemortem test for scrapie should be revaluated multiple times at the herd and 
individual level owing to influences by PrP genotype, scrapie strain, level of infection, and 
incubation period time-point.  
Bioassays using mice expressing transgenic PrPC are useful for testing the 
transmission efficacy of the scrapie agent. For example, Tg338 mice overexpress an ovine 
VRQ transgene,152,153 so these mice can be used to analyze sheep scrapie isolates. The effect 
of the species barrier on cross-species transmission is nullified by using a transgenic mouse. 
Furthermore, transgenic mice often overexpress PrPC. This allows prion diseases to be 
propagated in vivo more rapidly with greater sensitivity than in a natural host that may take 
years under normal conditions. For example, for the classical scrapie strain x124 derived 
from an VRQ/ARR sheep, the incubation time in intranasally inoculated sheep with the 
VRQ/ARQ genotype is 9.9 to 13.9 months.131 Tg338 mice will succumb to the same 
inoculum in approximately 76 days [internal unpublished data, USDA ARS, Ames, IA]. The 
rapid incubation of prion diseases in transgenic mouse models allows experimentation to be 
performed at faster and less expensive rates than studies in the natural host.  
Mouse models are also widely used for strain typing prion diseases. For this 
technique, the degree of vacuolation in predefined grey matter and white matter locations is 
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plotted to compare strains.127 Wild type inbred mice, C57b, RIII, and VM are regularly 
utilized; however, due to species barrier effects, low transmission attack rates can preclude 
comparisons with inbred mice. As an alternative, using transgenic mice that express the host 
species’ PrPC can result in higher attack rates and shorter incubations.153,154 For example, 
scrapie strain 13-7 has a 5.9% (1/17) attack rate in C57BL/6 mice on primary passage,131 but 
in Tg338 mice, the attack rate is 100% (17/17) [internal unpublished data, USDA ARS, 
Ames, IA].  
In vitro assays have been developed to identify prions for more rapid diagnostic and 
experimental purposes. Protein misfolding cyclic amplification (PMCA) is conceptually 
analogous to PCR amplification of DNA. For this method, a sample containing prions is 
added to a brain homogenate from a normal animal and subjected to alternating steps of 
incubation and sonication.155 Small amounts of undetectable prions are eventually amplified 
to detectable levels by western blotting. An improved method (rPrP-PMCA) using PK 
sensitive recombinant PrP (rPrPsen), decreased the assay time from 3 weeks to a couple of 
days.156 By adding PrPSc, rPrPsen is converted to detectable rPrPres (PK resistant) via 
sonication.  
Quaking induced conversion (QuIC) is an alternative to PMCA that employs shaking 
instead of sonication.157 The original QuIC technique identified prions from a sample within 
a day; however, the original detection method relied on laborious western blotting. An 
improved version of QuIC called real-time QuIC (RT-QuIC) exploits the fluorescence of 
thioflavin T interacting with amyloid fibrils.158,159 The fluorescence-based assay utilizes a 
plate reader and measures the intensity of fluorescence in response to amyloid formation. By 
establishing a standard curve, this technique has been adapted to quantify amount of prions in 
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a sample.160 A more recently described variation of QuIC called endpoint-QuIC (EP-QuIC) 
utilizes a thermomixer instead of a plate reader to perform shaking.161 The same research 
group later reported distinct differences in the detection thresholds between conventional RT-
QuIC and EP-QuIC at various time intervals.162 The utility of RT-QuIC and ELISA-coupled 
PMCA extends beyond diagnostic detection of PrPSc. RT-QuIC has also been used to 
discriminate prion strains.163,164  
The stability of folded prions varies between some TSE strains, and by denaturing 
prions with increasing concentrations of guanidine hydrochloride (GdnHCl), strains can be 
segregated into distinct groups.165 After GdnHCl denaturation, the relative amount of prion 
remaining is expressed in terms of relative absorbance as determined by ELISA.166,167 One 
example of this technique’s application is the its ability to distinguish isolates of scrapie in 
sheep.168 
 
Interspecies Transmission of the Scrapie Agent 
The transmission of TSEs between animals of different species is often impeded by a 
species barrier that is related to differences between the host and donor PRNP sequence. A 
prime example of a robust species barrier is seen with dogs. Dogs are highly resistant to 
prion infection and have not been shown to be susceptible to TSEs in vivo.169 This example 
epitomizes the “species barrier” concept. Contrariwise, there are instances of natural TSE 
transmission between species. Two examples would be the transmission of C-BSE to 
humans,170-172 and likely, L-BSE to mink.173,174 Experimentally, interspecies transmission 
studies are used to evaluate host ranges and the origins of TSEs. The results inform policy 
decisions regarding biosecurity, food security, and the use/disposal of specified risk material.  
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Experimental transmission of scrapie to cattle is sometimes precluded by a significant 
species barrier. Cattle appear to be resistant to a U.S. derived scrapie strain by the oral 
route.175 However, cattle are susceptible to intracerebral inoculation.176,177 Cattle that develop 
scrapie do not exhibit spongiform change and mainly have PrPSc immunolabeling visible 
within neurons. Notably, this disease phenotype in scrapie affected cattle does not resemble 
BSE in cattle, refuting the hypothesis that scrapie is the etiologic agent of BSE.  
North American white-tailed deer are susceptible to the agent of classical scrapie by 
intracerebral and oral inoculation routes.178,179 Interestingly, deer intranasally inoculated with 
scrapie, simulating a natural route of exposure, accumulated PrPSc with distinct molecular 
phenotypes on western blot. Depending on the brain region examined, the deer had a lower 
unglycosylated band similar to the original scrapie inoculum or a higher unglycosylated band 
similar to CWD isolates.180 Elk are also susceptible to the scrapie agent after experimental 
intracranial inoculation.181 Scrapie-affected elk exhibit a PrPSc immunophenotype similar to 
scrapie inoculum and distinct from cervids with CWD, indicating that the origin of CWD in 
elk is not likely directly from sheep with scrapie. 
There are several other experiments aimed at determining the host range of scrapie. 
For example, classical scrapie has been successfully transmitted to raccoons via intracerebral 
inoculation;182 although, they are resistant to atypical scrapie.183 Swine are poorly susceptible 
to the agent of scrapie, and in intracerebrally inoculated swine, the disease phenotype is 
different than in sheep with scrapie.184 In a study of pigs intracranially inoculated with 
scrapie, no positive animals were detected at market weight by traditional diagnostic methods 
(ELISA, IHC, and WB), but 5/10 aged pigs (51 months old) were positive by one or more 
traditional diagnostic techniques.184 No orally inoculated pigs had detectable PrPSc by 
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traditional methods, but a mouse bioassay did demonstrate some mice with evidence of PrPSc 
accumulation after inoculation with brain material.  
The zoonotic potential of scrapie has been investigated. Generally, the likelihood of 
zoonosis is considered to be low, since there are no reported human TSE cases with scrapie 
compatible phenotypes.185 There are, however, comparative models that suggest zoonotic 
potential. For example, Cassard et al. demonstrated that a subset of transgenic mice 
overexpressing human prion protein were susceptible to various strains of classical scrapie; 
albeit, there was a notable species barrier in place considering that the mice overexpressed 
PrPC and the attack rates were low.186 Non-human primates including various new world and 
old world monkeys have been susceptible to the scrapie agent, often after a significantly long 
incubation period.5,187,188 
 
Transmission of Non-Scrapie TSE Agents to Sheep 
Sheep are susceptible to several TSEs originating in other species. In the early 
1990’s, experimental transmission of classical BSE to sheep was prompted by investigations 
into the origins of BSE in cattle. Sheep were shown to be susceptible to C-BSE by both oral 
and intracranial inoculation.189 However, there are notable differences in the distribution of 
C-BSE in sheep compared to cattle. In sheep the spleen is infectious; whereas, in cattle the 
spleen does not harbor infectious PrPSc.190,191 Furthermore, C-BSE inoculated sheep have a 
variety of other infectious tissues including the distal ileum (ENS), Peyer’s patches, spleen, 
liver, mesenteric lymph nodes, prescapular lymph nodes, tonsils, and thymus.192 Sheep are 
most susceptible to C-BSE prior to weaning.193 Further investigations into the presence of 
BSE within small ruminant populations demonstrate that BSE can spread within a closed 
population of sheep by either in utero or perinatal exposure.194 Although experimental 
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evidence demonstrates that sheep could be a reservoir for BSE, widespread surveillance 
within the BSE epizootic region has failed to substantiate this concern.195  
Attempted transmission of atypical BSE agents to sheep has had variable success 
depending on the inoculation route. Intracranial inoculation of the atypical BSE (L-BSE) 
agent in sheep results in disease, but sheep are not susceptible orally. Sheep affected by L-
BSE lack peripheral lymphoreticular PrPSc, but they have detectable PrPSc in peripheral 
nervous tissues including various ganglia and neuromuscular spindles.196 Sheep PRNP 
genotype influenced their susceptibility to intracranial inoculation with the L-BSE agent. 
Sheep with the ARR/ARR genotype did not developed disease, but sheep with VRQ/VRQ, 
VRQ/ARQ, and ARQ/ARQ genotypes were susceptible. Subsequent passage of sheep 
adapted L-BSE prions to sheep resulted in a substantial decrease in the incubation period, 
suggesting enhanced adaptation of L-BSE to sheep.  
Transmission of the chronic wasting disease agent from mule deer (CWDMD) to sheep 
has been demonstrated after intracranial inoculation of sheep with VRQ/ARQ and 
ARQ/ARQ genotypes.197 A single sheep with the VRQ/ARQ genotype, developed neurologic 
signs at 35 months post-inoculation. This sheep had spongiform encephalopathy and 
widespread lymphoid accumulation of PrPSc throughout the body including the tonsils, lymph 
nodes, and spleen. One subclinical sheep with the ARQ/ARQ genotype had spongiform 
change and PrPSc accumulation in the brain and tonsils that was noted at the termination of 
the study (72 months post-inoculation). Sheep with a more resistant genotype, ARQ/ARR, 
did not have detectable PrPSc or spongiform change.  
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Scrapie Eradication in the United States 
There is an ongoing effort to eradicate scrapie in the United States. The U.S. scrapie 
eradication program focuses on several primary areas including genetic susceptibly testing, 
selective breeding of rams with a resistant genotype, an indemnification program, and 
surveillance.198 The components of surveillance are regulatory scrapie slaughter surveillance 
(RSSS), non-slaughter surveillance (on-farm and trace investigations), and the scrapie free 
flock certification program (SFCP).199 The surveillance program aims to test a minimum of 
40,000 animals (sheep and goats) each year on farms and through RSSS. While scrapie is not 
completely eradicated, the program has seen considerable success in the past twenty years. 
According to the 2017 annual report, the incidence of positive cull sheep at slaughter 
between 2003 and 2017 has decreased by 99%.200 Furthermore, infected and source flocks 
decreased dramatically from 2006 to 2016.  
 
Summary 
Scrapie is a naturally occurring and fatal neurologic disease of sheep that is caused by 
a misfolded protein called a prion. The tendency to transmit disease between individual sheep 
is influenced by the donor and host’s prion protein genotype. Sheep with the ARR/ARR 
genotype are considered to be relatively resistant; whereas, sheep that have a VRQ/VRQ 
genotype are highly susceptible to classical scrapie. Antemortem diagnosis of scrapie can 
provide valuable information to confirm suspected positive cases, but negative results should 
be interpreted with caution and in light of repeated sampling. One aim of future work is 
toward improved methods for preclinical detection. Another area of future work will be to 
continue probing historical and novel scrapie strains for characteristics that help elucidate 
their origins, pathogenesis, and host ranges. Although experimental interspecies transmission 
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of prion agents is sometimes possible, it is generally considered unlikely to occur under 
natural conditions. The U.S. scrapie eradication program has demonstrated successful results 
with a substantial decrease in cases throughout the program’s tenure. 
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Abstract 
Scrapie is a fatal neurodegenerative disease of sheep resulting from the accumulation 
of a misfolded form of the prion protein (PrPSc). Polymorphisms in the host prion protein 
gene (PRNP) can affect susceptibility to the scrapie agent. Lysine (K) at codon 171 of PRNP 
is an inadequately characterized, naturally occurring polymorphism in sheep. We inoculated 
Barbado sheep with PRNP genotypes QQ171, QK171 or KK171 by either the intracranial 
(IC, n=2-7 per genotype) or oronasal (ON, n=5 per genotype) routes with a scrapie isolate to 
investigate the effect of lysine at codon 171 on susceptibility. When neurologic signs were 
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observed or at the end of the experiment (70 months post-inoculation (MPI)), sheep were 
necropsied and tissue collected for histopathologic, immunohistochemical, enzyme 
immunoassay and western blot examination for PrPSc. All genotypes of sheep developed 
scrapie after IC inoculation. After ON inoculation, sheep with the QK171 genotype had 
prolonged incubation periods compared to the QQ genotype. During the experiment, 2/5 of 
the ON-inoculated QK genotype sheep developed neurologic signs and had PrPSc in the brain. 
The other 3/5 sheep were asymptomatic at 70 MPI, but had detectable PrPSc in peripheral 
tissues. None of the ON-inoculated sheep of the KK171 genotype developed signs or had 
detectable PrPSc. Our experiments demonstrate that sheep with the KK171 genotype are 
resistant to scrapie via oronasal exposure and that sheep with the QK171 genotype have 
prolonged incubation relative to QQ171 sheep. The K171 prion protein allele may be useful 
to enhancing scrapie resistance in certain breeds of sheep. 
 
Introduction 
Transmissible spongiform encephalopathies (TSE) are fatal neurodegenerative 
diseases that affect multiple species. Scrapie is the naturally occurring TSE of sheep and 
goats.18,24,29 The causative agent is a misfolded form of the prion protein (PrPSc) which is 
self-replicating and infectious.7,28 Sheep are susceptible via natural exposure to PrPSc both 
vertically from mother to offspring and horizontally between unrelated animals in a flock.8,30  
The normal cellular prion protein (PrPC) is encoded by an endogenous gene, PRNP.27 
Allelic variation in PRNP codons 136, 154 and 171 produces amino acid polymorphisms in 
PrPC that correlate with varying degrees of scrapie susceptibility in sheep.5,9,10 Alanine (A) 
136 and arginine (R) 171 lend relative resistance while valine (V) 136 and glutamine (Q) 171 
correlate with an increased risk for developing scrapie. Arginine 154 has a minor association 
39 
with scrapie susceptibility. Ultimately, disease susceptibility is influenced primarily by the 
136/171 haplotype with a distinct influence imparted by codon 171.4,5,11,21 The 
A136R154R171/ARR and ARQ/ARR haplotypes are associated with relative resistance while 
ARQ/ARQ is linked to scrapie susceptibility.4,15 Homozygosity for Q171 increases 
susceptibility whereas a survival advantage exists with heterozygosity (e.g. QR171).21,34 
The effect of common amino acid polymorphisms at codon 171 (Q171, R171) on 
scrapie susceptibility has been investigated.14,21,32 However, little is known about the 
contribution of lysine (K) other than the presence of naturally occurring scrapie affecting 
heterozygous K171 sheep in Greek and Italian sheep.1,6 K171 has a relatively higher 
incidence in some Mediterranean breeds and also occurs in other breeds seen in the U.S. 
including Barbado, Barbado/St Croix, Dorper and Suffolk crosses.2,17 Non-random sampling 
of flocks in the U.S. has also identified the polymorphism in American Blackbelly, Black 
Hawaiian, Painted Desert, and Texas Dall sheep (D. Sutton and D. Norden, personal 
communication, unpublished data USDA APHIS, 2017). For regulatory purposes, the current 
scrapie eradication program in the U.S. considers sheep with Q, H, and K at position 171 
equally susceptible to scrapie.3 Therefore, determining the contribution of K171 to scrapie 
susceptibility could impact breeding programs by allowing retention of otherwise desirable 
rams.  
We previously reported a prolonged incubation period in heterozygous QK171 
Barbado sheep intracranially (IC) inoculated with the scrapie agent.16 The purpose of the 
current study was to compare the relative susceptibility of sheep with PRNP encoding 
QQ171, QK171, or KK171 after either IC or oronasal (ON) inoculation with a US-derived 
scrapie isolate.  
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Materials and Methods 
Animal procedures 
Animals for this experiment were sourced from a known scrapie-free flock housed at 
the USDA National Animal Disease Center (NADC) in Ames, IA. Approval from the 
Institutional Animal Care and Use Committee was obtained prior to conducting this 
experiment (protocol number 3893). PRNP genotypes were sequenced by PCR using 
previously described methods.15 Amino acid sequences of the prion protein were predicted 
from the genotypes; they were determined to be homozygous at other potentially 
polymorphic sites M112, G127, A136, M137, S138, L141, R151, R154, M157, N176, H180, 
Q189, T195, T196, R211, Q220, and R223. For this study, genotype polymorphisms were 
documented at codon 171: QQ171, QK171, or KK171. The experimental groups comprised 
sheep with QK and KK genotypes while the QQ genotype served as a positive control. Sheep 
in the IC experiment were inoculated at 11 months old except the 2 positive controls (QQ) 
that were retired breeding ewes (24 and 59 months of age). All lambs in the ON experiment 
were inoculated at approximately 3 months of age.  
 
Scrapie isolates and animal procedures 
A classical scrapie isolate from the continental United States (No. 13-7) was serially 
passaged four times through ARQ/ARQ Suffolk sheep prior to use as an inoculum in the 
current experiment.19 Brain tissue was mechanically ground, 100 µg/ml of gentamicin was 
added, and the final homogenate was prepared as a 10% (w/v) solution with phosphate-
buffered saline. Lambs from each genotype group were experimentally infected as described 
below. 
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The procedure for intracranial inoculation has been described.16,20 Briefly, the sheep 
were sedated with xylazine and the dorsal frontal region was surgically prepared prior to 
making a 1 cm midline incision caudal to the junction of the parietal and frontal bones. A 1 
mm hole was drilled through the underlying bone. A 22-gauge spinal needle was inserted 
through the hole to the ventral aspect of the calvarium where 1 ml of inoculum was injected 
slowly as the needle was withdrawn. The skin incision was closed with tissue glue. Oronasal 
inoculation was performed as previously described.25 Briefly, the head was elevated slightly, 
and 1 ml of inoculum was deposited into the right nostril via a needle-less syringe.  
All inoculated sheep were housed in biosafety level 2 facilities for two weeks 
following exposure to scrapie. After this period, the sheep were moved to outside pens at the 
National Animal Disease Center. Animals were fed a pelleted growth and alfalfa hay ration.  
Sheep were monitored daily for clinical signs consistent with scrapie. Necropsy was 
performed when unequivocal clinical signs occurred or at the pre-determined end of the 
study (70 months post-infection).  
 
Sample collection and processing 
At necropsy, duplicate tissue samples were collected and stored in 10% buffered 
neutral formalin (globes in Bouin’s fixative) or frozen. Specifically, tissues were collected 
from brain, spinal cord, pituitary, trigeminal ganglia, eyes, sciatic nerve, third eyelid, palatine 
tonsil, pharyngeal tonsil, lymph nodes (mesenteric, retropharyngeal, prescapular and 
popliteal), spleen, esophagus, forestomaches, intestines, rectal mucosa, thymus, liver, kidney, 
urinary bladder, pancreas, salivary gland, thyroid gland, adrenal gland, trachea, lung, 
turbinate, nasal planum, heart, tongue, masseter, diaphragm, triceps brachii, biceps femoris, 
and psoas major. 
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Microscopic and immunohistochemical evaluation 
To study the accumulation of PrPSc in tissue, bright-field microscopy was used in 
combination with immunohistochemistry. Paraffin-embedded tissues were sectioned at their 
optimum thickness (brain 4 µm, lymphoid 3 µm, other 5 µm). The presence of PrPSc and the 
pathologic phenotype (immunolabeling pattern and distribution) were evaluated by 
application of a cocktail containing two monoclonal antibodies (F89/160.1.5 and F99/97.6.1) 
each used at a concentration of 5 µg/ml utilizing an automated processor.25 Descriptions of 
the PrPSc immunolabeling patterns have been published previously.12,31 Hematoxylin and 
eosin (HE)-stained sections of brain were evaluated for evidence of spongiform change in 
each animal.  
 
Western blot 
To evaluate the molecular characteristics of PrPSc, western blot detection was 
performed on the frozen sections of brainstem at the level of the obex from representative 
samples of each genotype and inoculation group. The assay was performed as previously 
described16 utilizing monoclonal antibody P4 (0.1 µg/ml; R-Biopharm, Inc., Marshall, MI), a 
biotinylated anti-mouse secondary antibody (0.1 µg/ml; Biotinylated anti-mouse IgG, 
Amersham Biosciences, USA, Waltham, MA), and streptavidin horseradish-peroxidase 
conjugate (dilution 1∶10,000; Streptavidin horseradish-peroxidase conjugate, Amersham 





A commercially available enzyme immunoassay (HerdChek®, IDEXX Laboratories 
Inc., Westbrook, ME) was used to detect the presence of PrPSc in brainstem at the level of the 
obex, retropharyngeal lymph node and palatine tonsil. Assays were conducted according to 
kit instructions except that the samples were prepared as a 20% (w/v) tissue homogenate. 
Cut-off numbers were determined with a negative control per kit instructions; values greater 
than the mean optical density of negative controls + 0.180 were considered positive. 
 
Definitions 
To analyze experimental data, the following definitions were utilized. The attack rate 
was defined as the percentage of sheep from an experimental group that had detectable PrPSc 
in any tissue. Incubation period was defined as the amount of time that elapsed between 
inoculation and euthanasia at the onset of clinical signs.  
 
Results 
Attack rate and incubation period 
All of the IC-inoculated sheep developed clinical disease and had detectable PrPSc in 
the brainstem based on immunohistochemistry (100% attack rate). Differences in the 
incubation period were associated with route of inoculation and genotype at codon 171. 
Among the IC-inoculated sheep, the mean incubation periods for QQ, QK and KK genotypes 
were 8.8, 26.6 and 49.4 months post-inoculation (MPI), respectively (Table 1; Figure 1).  
The attack rates for sheep with QQ, QK and KK genotypes inoculated via the ON 
route were 100%, 100% and 0%, respectively. The QQ and QK genotypes of ON-inoculated 
sheep with neurologic signs had mean incubation periods of 21.6 and 52.7 months 
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respectively (Table 1; Figure 2). At the experimental endpoint (70 MPI), none of the sheep 
with the KK genotype had developed clinical signs.  
 
PrPSc accumulation in intracranially inoculated sheep 
To investigate the microscopic changes in the brain, HE-stained sections of brain 
were evaluated for spongiform change. Spongiform change occurred in the brainstem of all 
IC-inoculated sheep. Immunolabeled sections of brain, spinal cord and peripheral tissues 
were examined for PrPSc accumulation. PrPSc accumulation occurred throughout the central 
nervous system in all IC-inoculated sheep. Differences were observed in the PrPSc 
accumulation patterns between genotypes and were most prominent in the frontal cortex 
(Figures 3-8) and cerebellum. 
In the neocortex of sheep with the KK and QK genotype (Figures 3-4, 6-7), PrPSc was 
found primarily within the white matter and associated with extracellular accumulation of 
PrPSc in glial cells (stellate and perivacuolar immunolabeling types). In sheep with the KK 
genotype, PrPSc accumulation in neocortical gray matter was characterized by moderately 
dense aggregated, granular and plaque-like deposits that were most commonly present in the 
deeper cortical layers (external pyramidal through the polymorphic layer). In contrast, in 
sheep with the QQ genotype (Figures 5, 8) most of the PrPSc was present in the gray matter 
with stellate, linear and aggregated deposits particularly in the molecular and internal 
pyramidal layers. In the gray matter of sheep with the QK genotype, intraneuronal, intraglial 
and granular immunolabeling types were most prominent in the internal pyramidal layer. 
There was also a patchy distribution of linear type immunolabeling throughout the neocortex.  
The patterns of PrPSc accumulation in the cerebella of sheep with the QK or KK 
genotypes were similar to each other and different to those of sheep of the QQ genotype. 
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Similar to what was observed in the neocortex, white matter accumulation of PrPSc was rare 
in the cerebella of sheep with the QQ genotype and common in sheep with the QK and KK 
genotypes. Patterns of PrPSc accumulation in the granular and molecular layers were similar 
across all genotypes with moderate but variable amounts of granular, intraneuronal and 
intraglial PrPSc in the granular cell layer and scant punctate, granular and stellate deposits 
within the molecular layer. There was a small amount of intraneuronal PrPSc within Purkinje 
cells.  
Spinal cord sections (cervical, thoracic and lumbar) were immunoreactive for PrPSc in 
all sheep. PrPSc accumulation occurred primarily in the gray matter with increasing white 
matter involvement in QK and QQ genotypes. Immunolabeling patterns included 
intraneuronal, granular and intraglial.  
There was limited peripheral accumulation of PrPSc in intracranially inoculated sheep 
as evidenced by immunohistochemistry. Only 3/7 sheep with the QK genotype had 
detectable PrPSc within the retropharyngeal lymph nodes (RPLN) compared to 2/2 of the QQ 
genotype sheep (Table S1). In sheep with the KK genotype, 1/5 sheep accumulated PrPSc in 
the RPLN; however, immunoreactivity was present only as a few scattered positive cells in a 
single follicle. A single sheep from the QK group had PrPSc within a lymphoid follicle in the 
spleen. None of the IC-inoculated sheep had PrPSc within the palatine tonsil, pharyngeal 
tonsils or the rectal mucosal associated lymphoid tissue by means of IHC; however, one 
sheep with a QQ genotype had detectable PrPSc by EIA in the palatine tonsil.  
 
PrPSc accumulation in oronasally inoculated sheep 
To assess the pathological changes and PrPSc accumulation in sheep inoculated by the 
ON route, we evaluated HE-stained and immunolabeled sections of brain, spinal cord and 
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peripheral tissues by light microscopy. At the end of experiment (70 months), all the sheep 
with the KK genotype were euthanized without developing clinical signs suggestive of 
scrapie. No immunoreactivity for PrPSc was detected within the CNS of any sheep with the 
KK genotype as compared to 2/5 of the sheep with the QK genotype and 5/5 of the QQ 
(Table S1). These same animals had spongiform change in their brainstems. Overall, the 
pathologic phenotype (PrPSc pattern and distribution) was similar (Figures 9-10), but 
differences in the amount of PrPSc deposition within genotypes (intragenotypic) and between 
genotypes (intergenotypic) were observed. This was prominently displayed by more intense 
stellate labeling in the superficial cortex of sheep with the QQ genotype. The intragenotypic 
difference was observed in sheep with a QQ genotype; there was a positive correlation 
between incubation period and amount of PrPSc deposition. The intergenotypic differences 
were most evident in the neocortex. PrPSc deposition was greater in sheep with the QQ 
genotype compared to the QK genotype despite a longer incubation period for the QK 
genotype. 
There was no evidence of accumulation of PrPSc in any non-CNS tissues from sheep 
with the KK genotype. In contrast, QK and QQ genotypes had variably distributed PrPSc 
within the gastrointestinal (myenteric and submucosal ganglionic plexuses), lymphoreticular 
and peripheral nervous systems (Table 2 and Figures 11-14).  
 
Western blot 
Molecular profiles obtained from a western blot of brain homogenates from each 
sheep were identical to each other and the donor inoculum (Figure 15). Homogenized brain 




In this study, we assessed the effect of lysine at codon 171 of PRNP on the 
susceptibility of sheep to the scrapie agent. We demonstrated that, in our challenge model, 
the KK171 genotype confers resistance to the scrapie agent via ON inoculation and a 
prolonged incubation period after IC inoculation. Our results also reveal a prolonged 
incubation period in sheep with a heterozygous PRNP genotype (QK) as compared to the QQ 
genotype when inoculated via both the IC and ON routes. 
We utilized ON inoculation to simulate natural exposure to scrapie and found that 
sheep with the KK genotype are resistant (0% attack rate) similar to orally inoculated sheep 
with the ARR/ARR genotype.13,23 The reason for comparable susceptibility between these 
amino acid polymorphisms, lysine (K171) and arginine (R171), could be attributable to 
similarities between the functional groups in their side chains. The amino (lysine) and 
guanidino (arginine) groups are both basic and have similar isoelectric points (9.7 and 10.8). 
By comparison, glutamine (Q) has a non-basic nitrogen side chain that contains an amide 
functional group and has an isoelectric point of 5.7.33  
After ON inoculation, prolonged incubation periods occurred in sheep with the 
heterozygous QK genotype compared to sheep with the QQ171 genotype. Only 2/5 of the 
sheep with the QK171 genotype developed neurologic signs and accumulated PrPSc in the 
brain. The remaining 3/5 sheep accumulated PrPSc in peripheral tissues but did not develop 
neurologic signs before the experimental endpoint at 70 MPI. The mean incubation period in 
QK171 genotype sheep with clinical signs (52.7 MPI) was much longer than the mean 
incubation period observed in sheep with the QQ genotype (21.6 MPI). The presence of PrPSc 
in peripheral tissues of all ON-inoculated sheep of the QK genotype indicates that they are 
susceptible to the classical scrapie agent (strain 13-7) despite a prolonged incubation period.  
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These findings suggest that the resistance imparted by the QK171 genotype is similar 
but weaker than the QR171 genotype. For example, orally inoculated Cheviot lambs with the 
ARQ/ARR genotype exhibited prolonged incubation times compared to the ARQ/ARQ 
genotype.13 This is similar to the difference between ARQ/ARK and ARK/ARK in the 
present study; however, differences in experimental design involving scrapie strain (13-7 vs. 
RBP1) and inoculum volume (0.1 g once vs. 1 g repeated for 5 days) make direct 
comparisons between these studies difficult. We previously used the No. 13-7 scrapie agent 
to conduct an oral challenge of neonatal Suffolk lambs of the QR genotype, but there was no 
evidence of transmission.15 The present study used identical methods with respect to 
inoculum volume and scrapie strain, but we observed a 100% attack rate in the QK genotype. 
This suggests that heterozygous arginine may have a stronger effect on resistance than lysine. 
That hypothesis is consistent with recently published investigations of naturally occurring 
scrapie in herds with relatively high frequencies of ARK haplotypes. The authors reported 
that K171 was the second most resistant allele after arginine (R>K>H>Q).6 
Evaluation of IHC stained tissues from IC-inoculated sheep revealed intergenotypic 
differences in PrPSc phenotypes (pattern and distribution). White matter immunolabeling was 
largely present in the KK and QK genotype contrasting a relative absence in sheep with the 
QQ genotype. In sheep with the QK genotype, neocortical immunolabeling resembled an 
amalgamation of the KK and QQ phenotypes. It is unclear to what extent serial passage in 
ARQ/ARQ genotype sheep influenced these differences, and it’s possible that a QK 
genotype-adapted strain would impart a different phenotype. Since PrPSc in scrapie-infected 
sheep is predominantly composed of the susceptible allelic protein isoform,22,26 we expected 
that even in IC-inoculated animals the QK group’s pathologic phenotype would more closely 
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resemble the QQ phenotype, because Q171 is more susceptible to conversion. Instead we 
observed a “combined” phenotype. This finding suggests that a combination of PrPSc 
containing both K and Q at codon 171 was present. Quantification of the PrPSc allotype 
composition in these sheep would be useful to further evaluate differential expression of 
protein isoform fractions between genotype and inoculation groups.  
The results of the present study indicate that sheep with a homozygous lysine-171 
(KK171) genotype are resistant to scrapie via oronasal exposure in our challenge model, and 
that sheep with the heterozygous genotype (QK171) have prolonged incubation periods. 
These findings may be useful in designing breeding programs to enhance scrapie resistance 
in breeds of sheep that carry the K171 prion protein allele. 
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Figure 1. A survival plot of Barbado sheep that were intracranially inoculated with the No. 
13-7 scrapie agent. The survival curves for the KK, QK and QQ genotypes are illustrated by 
the short dash, long dash and solid lines, respectively. 
 
 
Figure 2. A survival plot of Barbado sheep that were oronasally inoculated with the No. 13-7 
scrapie agent. The survival curves for the KK, QK and QQ genotypes are illustrated by the 




Figures 3-8. Scrapie, intracranial inoculation, neocortex, sheep. Immunohistochemistry for 
PrPSc, monoclonal antibodies F89/160.1.5 and F99/97.6.1. Figure 3 and 6. Sheep with a 
KK171 genotype have prominent glial-associated stellate immunolabeling in the white 
matter. In the gray matter, there are aggregated, granular and plaque-like deposits in deeper 
cortical layers. Figure 4 and 7. Sheep with a QK171 genotype have similar white matter 
immunolabeling to the KK genotype: stellate and perivacuolar immunolabeling types. The 
cortex is characterized by intraneuronal, intraglial and granular immunolabeling types 
predominantly in the internal pyramidal layer. Linear immunolabeling is present within the 
internal granular and external pyramidal layers. Figure 5 and 8. Sheep with a QQ171 
genotype predominantly have gray matter labeling types: stellate, linear and aggregated 
deposits primarily in the molecular and internal pyramidal layers. In contrast to sheep with a 




Figures 9-10. Scrapie, oronasal inoculation, neocortex, sheep. Immunohistochemistry for 
PrPSc, monoclonal antibodies F89/160.1.5 and F99/97.6.1. Figure 9. A sheep with the QK171 
genotype has scattered transcortical stellate (arrowheads) and punctate immunolabeling. 
There is also punctate, linear (arrow) and mild intraglial immunolabeling in the pyramidal 
layers. The white matter contains stellate and punctate immunolabeling types. Figure 10. A 
sheep with the QQ171 genotype contains similar immunolabeling types as the QK genotype; 
however, stellate immunolabeling is present more broadly affecting the deep cortical layers. 




Figures 11-14. Scrapie, oronasal inoculation, sheep. Immunohistochemistry for PrPSc, 
monoclonal antibodies F89/160.1.5 and F99/97.6.1. Figure 11. The pharyngeal tonsil from a 
sheep with the QK171 genotype contains of PrPSc immunolabeling. There was no detectable 
PrPSc in the CNS of this sheep. Figure 12. The trigeminal ganglion contains intraneuronal 
PrPSc from a sheep with the QK171 genotype. Figure 13. A sheep with the QQ171 genotype 
has detectable PrPSc in the neuromuscular spindle (cross-section) of the masseter muscle. 
Figure 14. The ileum of a sheep with the QQ171 genotype contains PrPSc within neurons of 




Figure 15. Western blot of brain homogenates from scrapie inoculated sheep developed with 
anti-PrPSc monoclonal antibody P4. Lane key: M, molecular mass marker. Lanes 1-3, 
intracranial inoculation: KK (1), QK (2), QQ (3). Lanes 4-6, oronasal inoculation: KK (4), 







Table 1. Summary of results by genotype of Barbado sheep inoculated with US scrapie isolate 13-7. 















Immunoblot   Brainstem Lymphoida 
KK 5 IC 5/5 49.4 100% 5/5 +  5/5 1/7 
QK 7 IC 7/7 26.6 100% 7/7 +  7/7 3/7 
QQ 2 IC 2/2 8.8 100% 2/2 +  2/2 2/2 
KK 5 ON 0/5 ND 0% 0/5 -  0/5 0/5 
QK 5 ON 2/5 52.7 100% 2/5 +  2/5 5/5 
QQ 5 ON 5/5 21.6 100% 5/5 +  5/5 5/5 
Abbreviations: IC, intracranial; ON, oronasal; IP, incubation period; MPI, months post-inoculation; SE, spongiform encephalopathy; 




Table 2. Non-CNS accumulation of PrPSc in oronasally 
inoculated Barbado sheep by genotype.a 
Tissue AA KK AA QK AA QQ 
        
Lymphoid      
Palatine tonsil - + + 
Pharyngeal tonsil - + + 
Retropharyngeal LN - + + 
Spleen - + + 
Mesenteric LN - - + 
Prescapular LN - + + 
Popliteal LN - + + 
RAMALT - + + 
     
Gastrointestinal     
Forestomachs - - + 
Small Intestines - + + 
     
Nervous System     
Retina - + + 
Trigeminal ganglia - + + 
     
Other     
Adrenal gland - + + 
Masseter muscle - - + 
Pituitary gland - + + 
aDesignated by + if at least 1 animal per genotype group 





Supplemental Table 1. Microscopic and enzyme immunoassay findings in different tissues of Barbado sheep inoculated with U.S. classical scrapie isolate 13-7 by 
intracranial or oronasal routes.  
              Brainstem   Immunohistochemistry (PrPSc) 









Histopath (SE) EIA   Brainstem  PHT PAL RPLN 
A 1 977 KK IC 55.4 Y + +   + - - + 
  2 913 KK IC 44.1 Y + +   + n/d - - 
  3 915 KK IC 46.2 Y + +   + - - - 
  4 919 KK IC 46.2 Y + +   + - - - 
  5 924 KK IC 55.4 Y + +   + - - - 
  6 978 QK IC 27.6 Y + +   + - - - 
  7 918 QK IC 27.4 Y + +   + - - - 
  8 912 QK IC 23.4 Y + +   + - - - 
  9 916 QK IC 24.6 Y + +   + - - + 
  10 925 QK IC 33.3 Y + +   + - - - 
  11 923 QK IC 28.4 Y + n/d   + - - + 
  12 922 QK IC 21.4 Y + n/d   + - - + 
  13 248 QQ IC 6.9 Y + +   + - - + 
  14 51 QQ IC 10.7 Y + +   + - IS + 
B 15 1004 KK ON n/a N - -   - - - - 
  16 1006 KK ON n/a N - -   - - - - 
  17 1013 KK ON n/a N - -   - - - - 
  18 1014 KK ON n/a N - -   - - - - 
  19 1020 KK ON n/a N - -   - - - - 
  20 1008 QK ON n/a N - -   - - - + 
  21 1005 QK ON n/a N - -   - - + + 
  22 1009 QK ON n/a N - -   - + - - 
  23 1023 QK ON 40.7 Y + +   + + + - 
  24 1007 QK ON 64.7 Y + +   + + + + 
  25 1010 QQ ON 21.9 Y + +   + - + + 
  26 1019 QQ ON 21.4 Y + +   + - + + 
  27 1002 QQ ON 19.8 Y + +   + + IS + 
  28 1012 QQ ON 19.4 Y + +   + + + + 
  29 1021 QQ ON 25.6 Y + +   + + + + 
Abbreviations: IC, intracranial; ON, oronasal; MPI, months post-inoculation; SE, spongiform encephalopathy; EIA, enzyme immunoassay; PHT, pharyngeal tonsil; 
PAL, palatine tonsil; RPLN, retropharyngeal lymph node; n/a, not applicable in non-clinical animals at experimental end-point (70 MPI); n/d, test not performed; 
IS, insufficient sample. 
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Abstract 
Transmissible mink encephalopathy (TME) is a food borne prion disease. 
Epidemiological and experimental evidence suggests similarities between the agent of TME 
and L-BSE. This experiment demonstrates the susceptibility of four different genotypes of 
sheep to the agent of TME by intracranial inoculation. The four genotypes of sheep used in 
this experiment had polymorphisms corresponding to codons 136 and 171 of the prion gene: 
VV136QQ171, AV136QQ171, AA136QQ171, and AA136QR171. All intracranially inoculated sheep 
without comorbidities (15/15) developed clinical scrapie and had detectable PrPSc by 
immunohistochemistry, western blot, and enzyme immunoassay (EIA). The mean incubation 
periods in TME infected sheep correlated with their relative genotypic susceptibility. There 
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was peripheral distribution of PrPSc in the trigeminal ganglion and neuromuscular spindles; 
however, unlike classical scrapie and C-BSE in sheep, ovine TME did not accumulate in the 
lymphoid tissue. To rule out the presence of infectious, but proteinase K susceptible PrPSc, 
the lymph nodes of two sheep genotypes, VV136QQ171 and AA136QQ171, were bioassayed in 
transgenic ovinized mice. None of the mice (0/32) inoculated by the intraperitoneal route had 
detectable PrPSc by EIA. Interestingly, mice intracranially inoculated with RPLN tissue from 
a VV136QQ171 sheep were EIA positive (3/17) indicating that sheep inoculated with TME 
harbor infectivity in their lymph nodes. Western blot analysis demonstrated similarities in the 
migration patterns between ovine TME and the bovine TME inoculum. Overall, these results 
demonstrate that sheep are susceptible to the agent of TME, and that the tissue distribution of 
PrPSc in TME infected sheep is distinct from classical scrapie. 
 
Introduction 
Transmissible spongiform encephalopathies (TSE) are infectious fatal 
neurodegenerative diseases caused by a misfolded form of the prion protein (PrPSc) (1, 2). 
There are numerous naturally occurring prion diseases in animals including bovine 
spongiform encephalopathy (BSE), scrapie in small ruminants, chronic wasting disease 
(CWD) in cervids, transmissible mink encephalopathy (TME), Creutzfeldt-Jakob disease 
(CJD) in humans, and camel prion disease (3-6). Genetically susceptible animals develop 
disease spontaneously or after exposure to contaminated feedstuffs, environments, or infected 
animals. 
Despite the infectious nature of PrPSc, there is often a hardy species barrier that 
precludes cross-species transmission (7). Nevertheless, food-borne prion diseases may infect 
humans and have economically devastating consequences on trade. Beginning in the mid-
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1980’s and peaking in 1996, the UK experienced an epizootic of BSE (classical BSE or C-
BSE) that evidenced the zoonotic potential of prion diseases (8). A variant of Creutzfeldt-
Jakob disease (vCJD) was identified in a subset of humans exposed to the agent of C-BSE in 
contaminated beef products (9-12). Due to the fatal consequences associated with zoonotic 
prions within the human food supply, substantial investigation has aimed at determining the 
origin of C-BSE. While the etiology of the original C-BSE case remains uncertain, it has 
been determined that feedback of BSE infected bovine carcasses likely amplified the 
outbreak (8, 13).  
In addition to C-BSE, atypical forms of BSE (L-type and H-type) occur 
spontaneously in older cattle at a much lower frequency (4). Atypical BSE types have 
distinct molecular phenotypes relative to C-BSE that are demonstrable by a lower or higher 
molecular mass of the unglycosylated PrPSc glycoform (14). One standing theory for the 
origin of C-BSE is its emergence from atypical BSE and subsequent transmission between 
cattle. This is supported by the emergence of classical BSE phenotypes after serial 
transmission of H-BSE strains in wild type mice (15, 16).  
Like C-BSE, transmissible mink encephalopathy (TME) is considered to be a food-
borne TSE. In a 1985 outbreak of TME in Stetsonville, WI, a TSE-affected downer cow may 
have been the source of prion disease in infected mink. Subsequent investigations revealed a 
lack of strain de-adaptation after transmission of TME between cattle and mink, reinforcing 
the hypothesis of a common origin (5). Furthermore, bovine TME (bTME) is phenotypically 
similar to L-BSE which also suggests that a downer cow may have been the source of TSE to 
the mink (17). This scenario supports the theory of naturally occurring interspecies 
transmission. With the aim of further characterizing the host range of the TME agent, we 
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investigated the susceptibility and disease phenotype of bovine passaged TME in sheep. 
Since TME has previously been demonstrated as similar to L-BSE, we also discuss the 
similarities between ovine TME (oTME) and previously published ovine L-BSE.  
 
Results 
Sheep were susceptible to the agent of TME by intracranial inoculation 
In order to test the susceptibility of sheep to TME, we intracranially inoculated 17 
sheep that had four different PRNP polymorphisms. All experimental sheep in the 
intracranial inoculation group developed scrapie-like neurologic disease except for two 
sheep. These two sheep were culled due to intercurrent disease at 10 months post-
inoculation. Neither of the culled sheep had detectable PrPSc in the CNS or peripheral tissues. 
Excluding animals with intercurrent disease that were removed from the study early, the 
attack rate was 100% (15/15) and the mean incubation periods were 29, 38, 40, and 52 
months for VVQQ, AVQQ, AAQQ, and AAQR genotypes, respectively. A survival plot for 
the intracranial inoculation group is illustrated in Figure 1. 
 
Intracranially inoculated sheep developed spongiform encephalopathy and had 
widespread PrPSc accumulation in the brain 
Hematoxylin and eosin stained sections of brain were evaluated for spongiform 
change in each animal. All genotypes of intracranially inoculated sheep had diffuse 
spongiform encephalopathy except for two sheep that were euthanized at 10 months post-
inoculation (MPI) due to intercurrent disease (Table 1).  
A cocktail of two antibodies, F89/160.1.5 and F99/97.6.1, directed against PrPSc was 
used to assess the distribution and immunolabeling types of PrPSc in the brain. There were 
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similar PrPSc immunolabeling profiles in the cerebrum and brainstem of each genotype 
characterized by particulate, intraglial, stellate, perineuronal and linear types. The sheep with 
an AAQR genotype varied by having more prominent linear and perineuronal labeling types 
in the neocortex (Figure 2A). This genotype also contained areas with vascular plaque-like 
accumulations and coalescing PrPSc (Figure 2B).  
The cerebellar PrPSc immunolabeling patterns were similar between all genotypes 
except AAQR with grey matter particulate and intraglial labeling in the granule cell layer 
accompanied by particulate, perineuronal and linear in the molecular layer (Figure 2C). 
There was minimal white matter PrPSc labeling in the cerebellum. The AAQR genotype had 
overall less immunolabeling; however, when present, there were patchy areas of intraglial, 
perineuronal, intraneuronal and particulate labeling patterns (Figure 2D).  
The cervical, thoracic, and lumbar spinal cords contained PrPSc in all genotypes. 
There was diffuse accumulation of PrPSc in the grey matter which was concentrated primarily 
in the dorsal horn. Immunolabeling types included particulate, intraglial, intraneuronal, and 
sometimes perineuronal. 
 
Immunoreactivity was present in the peripheral nervous system but not lymphoid 
tissues 
In order to evaluate peripheral tissue for the presence of PrPSc, we applied PrPSc 
specific antibodies, F89/160.1.5 and F99/97.6.1, to formalin fixed paraffin embedded tissue 
sections. We detected PrPSc in peripheral tissues of all four genotypes (Table 2) of sheep. 
Various sheep of the VVQQ, AVQQ and AAQQ genotypes had PrPSc within the 
neuromuscular spindles of the masseter (Figure 3A) and psoas major muscles. Except for the 
AAQR genotype, most sheep also had detectable immunolabeling of PrPSc in the trigeminal 
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ganglia (Figure 3B). Accumulation of PrPSc in the trigeminal ganglia and neuromuscular 
spindles is similar to the distribution of L-BSE in sheep (18). All genotypes of sheep had 
retinal PrPSc accumulation. A single sheep from the AAQR genotype group had PrPSc 
labeling in the myenteric plexus of the small intestinal enteric nervous system. Other tissues 
had variable PrPSc accumulation including the sciatic nerve, adrenal medulla and pituitary 
gland. Unlike classical scrapie and C-BSE in sheep, there was no immunohistochemical 
detection of PrPSc in lymphoreticular tissue. 
 
Sheep were not susceptible to the agent of TME by oronasal inoculation 
We assessed the susceptibility of sheep to TME agent after oronasal exposure. After 
incubation periods of 58 to 69 months, none of the oronasally inoculated animals (0/12) had 
spongiform encephalopathy nor was PrPSc detectable by IHC in brainstem at the level of the 
obex. The retropharyngeal lymph node, palatine tonsil, pharyngeal tonsil, and small 
intestines were also negative for PrPSc by IHC. Misfolded prion proteins were not detected in 
the brainstems nor retropharyngeal lymph nodes by enzyme immunoassay (EIA).  
 
The molecular profiles of brain tissues from sheep or cattle with TME can be 
distinguished by western blot using P4 antibody 
We were able to discriminate oTME from bTME. We analyzed the banding patterns 
of oTME using two separate antibodies that can discriminate scrapie from C-BSE and L-BSE 
(19-21). Both oTME and bTME were immunoreactive for Sha31 (Figure 4). With the P4 
antibody, oTME was immunoreactive; however, bTME was not immunoreactive. 
In order to further characterize the molecular profile of oTME, we compared it to 
other relevant prion strains of sheep and cattle using the Sha31 antibody (Figure 5). Different 
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TSE strains vary by their molecular banding pattern (molecular weight) of the 
diglycosylated, monoglycosylated, and unglycosylated PrPSc fragments (22). All samples for 
this blot were acetone precipitated, and the sample amounts were adjusted to obtain optimal 
banding densities. Overall, the banding pattern of oTME resembled the inoculum, third 
passage bTME (also seen in Figure 4 using non-enriched samples). The molecular profile of 
L-BSE was similar to both ovine and cattle passaged TME isolates. Scrapie had a distinct 
banding pattern compared to the TME and L-BSE samples. We did not observe 
intergenotypic differences in the molecular properties of oTME. 
 
Enzyme immunoassays for misfolded proteins were positive in samples from the brains 
of intracranially inoculated sheep 
As a rapid screening method for PrPSc, we used EIA to test the brainstem and lymph 
nodes of all experimental sheep. All sheep in the ON inoculation experiment were negative 
for PrPSc by EIA of the retropharyngeal lymph nodes and the brainstem at the level of the 
obex. A single sheep (#816, AVQQ) in the IC inoculation study had low positive O.D. 
(0.597) from the retropharyngeal lymph node. It was later determined to be negative by IHC. 
Excluding two sheep that died 10 MPI, all sheep (15/15) had positive brainstem samples 
(range O.D. 1.739 – 4.00). All positives were confirmed by IHC.  
 
Lymph nodes from TME-infected sheep are infectious. 
In order to rule out the possibility of undetectable infectious PrPSc within the 
retropharyngeal lymph nodes (RPLNs) of sheep with TME (VVQQ and AAQQ genotypes), 
we performed bioassays in ovinized (Tg338) mice. Four experimental groups of mice were 
inoculated with RPLN from VVQQ or AAQQ genotype sheep by either the IC or 
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intraperitoneal (IP) route. Three mice IC inoculated with RPLN from sheep #935 (VVQQ) 
were positive as detected by EIA with an O.D. >4.0. None of the mice (0/18) inoculated with 
RPLN homogenate from sheep #808 (AAQQ) and none of the mice (0/32) intraperitoneally 
inoculated developed clinical signs or had detectable PrPSc. 
 
Discussion 
In the context of prion diseases, the purpose of interspecies transmission studies is to 
determine plausible host ranges and investigate the origins of TSE strains. This study 
demonstrates the susceptibility of sheep to the agent of TME by intracranial inoculation. Our 
findings corroborate some similarities between TME and L-BSE. These findings are 
congruent with previous research implicating L-BSE as the source of TME, at least the TME 
strain from the 1985 Stetsonville, WI outbreak (5, 17). 
The tissue distribution of PrPSc in sheep with TME is similar to L-BSE in sheep. 
Sheep intracranially inoculated with L-BSE have accumulation of PrPSc in peripheral ganglia 
and neuromuscular spindles; however, they lack lymphoreticular PrPSc accumulation (18, 
23). Similar to sheep challenged with L-BSE, all genotypes of sheep in the current study, 
except AAQR sheep, had immunolabeling of peripheral neuromuscular spindles and 
trigeminal ganglia. None of the sheep with TME had detected PrPSc in lymphoid tissue by 
IHC. This observation is discordant to the findings of lymphoreticular accumulation of PrPSc 
in sheep with C-BSE (24) and scrapie (25). One sheep (#816; AAQQ) had a low positive 
EIA result from a RPLN sample. Subsequent evaluation by IHC did not detect PrPSc in that 
tissue. However, in some TSE strains, including atypical scrapie, peripheral tissues are 
negative by conventional PrPSc immunodetection, but they harbor infectivity that is 
demonstrable by mouse bioassay (26). In this study, we examined the infectivity of RPLNs 
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from two sheep genotypes (VVQQ and AAQQ) using a transgenic mouse bioassay. We 
detected infectivity in the RPLN from sheep #935 (VVQQ). None of the mice inoculated 
with RPLN homogenate from a sheep with the AAQQ genotype (#808) had a positive EIA 
result. For further characterization, subsequent passage of PrPSc from these positive bioassay 
mice is ongoing. Additionally, a bioassay testing infectivity of RPLN from sheep #816 with 
the AVQQ genotype (low positive EIA result and negative IHC) is currently underway; these 
results will be reported separately. 
The western blot migration patterns of oTME were identical for all sheep genotypes. 
We also compared oTME to other TSE strains that affect cattle and sheep. In both the non-
enriched and acetone precipitated western blots, oTME resembled the inoculum, bTME. In 
the acetone precipitated blot, we compared multiple TSE strains of ruminants. The TME 
strains were similar to L-BSE, and all strains were distinct from classical scrapie in sheep.  
We further scrutinized the molecular characteristics of oTME by staining with the N-
terminus antibody, P4. Differential binding of P4 near the protease cleavage site has been 
used to discriminate scrapie from some BSE strains (18-21). Briefly, classical scrapie is 
immunoreactive with the P4 antibody while L-BSE and C-BSE do not react. Ovine L-BSE is 
detectable with the P4 antibody, and therefore has a scrapie-like detectability (18). We 
observed that our inoculum (third pass bTME) was not detectable with the P4 antibody (C-
BSE/L-like), but oTME samples did react with P4 (scrapie-like). The gain of N-terminal 
antibody binding in oTME but not bTME suggests that host species PrP has some influence 
on P4 antibody binding.  
The susceptibility of sheep to cattle passaged TME is similar to previous work. The 
transmission of TME directly from mink (Idaho strain) to sheep (intracranially) was 
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previously documented (27); however, since that experiment occurred prior to the advent of 
PRNP genotyping techniques and the widespread use of anti-PrPSc IHC detection, it lacked 
sheep genotype and IHC information. In the present study, all genotypes of sheep were 
susceptible to IC inoculation, and the incubation period was associated with the genotype. 
The duration of the incubation period by genotype (VVQQ < AVQQ < AAQQ < AAQR) 
was consistent with the susceptibility of sheep to classical scrapie infection (28).  
We were unable to produce prion disease in sheep after oronasal inoculation with the 
TME agent from cattle. The possibility of oral transmission cannot be unequivocally rejected 
given the small sample size in our study (12 sheep). Other variables that influence 
susceptibility include the volume of inoculum and the age of inoculated animals (29, 30). For 
example, sheep older than 2-3 months old have reduced susceptibility to oral infection with 
BSE (31). An age-dependent decrease in susceptibility to prion disease corresponds closely 
with ileal Peyer’s patch involution in sheep (29). The volume of the inoculum is also a factor. 
In this study, we used 0.1 gram (1 ml of 10% w/v solution) of inoculum once, which has 
effectively transmitted scrapie orally to sheep in previous studies (32-34). Other studies have 
successfully used different volumes of scrapie inoculum in sheep: 1 gram repeated for 5 days 
(35). However, there are other potential natural routes of infection that were not evaluated in 
the present study. For example, intralingual transmission of TME in hamsters is 100,000-
times more efficient than the oral route (36). Based on that research, it is hypothesized that 
epithelial defects or abrasions in the tongue could predispose livestock to oral prion infection.  
Failed oral transmission of TME to sheep is similar to failed oral transmission of L-
BSE to sheep (18). However, concern for interspecies transmission should not be readily 
dismissed; the lack of transmission to one species may not accurately predict other species 
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barriers. Case-in-point, L-BSE does not orally transmit to sheep, but L-BSE has been orally 
transmitted to non-human primates (37) and humanized PrP transgenic mice (38, 39). These 
findings indicate the potential for L-BSE zoonosis. Consequently, there should remain a 
concern for human and livestock exposure to the agents of L-BSE and TME, which may 
actually be the same agent. The susceptibility of humanized transgenic mice to oTME is 
underway and will be reported in a future manuscript.  
The results of the present study indicate that sheep are susceptible to the agent of 
TME. Unlike classical scrapie in sheep, the agent of TME does not appear in lymphoid 
tissues. Instead non-lymphoid peripheral accumulation of PrPSc occurs similar to the reported 
distribution of experimental L-BSE in sheep. In this respect, our findings support a common 
origin with L-BSE. Future research utilizing a transgenic mouse model would be useful to 
further discriminate the observed phenotypes. 
 
Materials and Methods 
Animal procedures 
Experimental animals were sourced from a known scrapie-free flock housed at the 
USDA National Animal Disease Center (NADC) in Ames, IA. Approval from the 
Institutional Animal Care and Use Committee was procured prior to conducting this 
experiment (protocol number ARS-2871). PRNP genotypes were sequenced using previously 
described methods (34). Amino acid sequences of the prion protein were predicted from the 
genotypes; they were determined to be homozygous at other known polymorphic sites G127, 
M137, S138, L141, R151, R154, M157, N176, H180, Q189, T195, T196, R211, Q220, and 
R223. Two sheep in the intracranial inoculation group were heterozygous MT112. 
Experimental groups were composed of sheep with polymorphisms at codons 136 and 171; 
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there were four genotypes included in this experiment: VV136QQ171 (VVQQ), AV136QQ171 
(AVQQ), AA136QQ171 (AAQQ), and AA136QR171 (AAQR).  
 
Inoculum preparation 
Due to insufficient availability of the original mink derived TME isolate, a bovine 
TME isolate was used for this experiment. In a previous experiment, the agent of 
transmissible mink encephalopathy was passaged two times in cattle via intracranial 
inoculation (40). The inoculum for this experiment was passaged a third time and then 
prepared from brainstem at the level of the obex. The final inoculum was prepared as a 10% 
(w/v) homogenate.  
 
Animal inoculation 
Experimental inoculation of sheep was performed by two routes: oronasal and 
intracranial. The number of sheep for each genotype inoculated intracranially was VVQQ, 
n=5; AVQQ, n=4; AAQQ, n=4; and AAQR, n=4. The procedure for intracranial inoculation 
was performed as previously described (25, 41, 42) using 1 ml of brain homogenate. 
Oronasal inoculation also was performed as previously described and demonstrated to be 
effective for the transmission of the scrapie agent (32, 33). Briefly, the head was elevated 
slightly, and 1 ml of the inoculum was deposited into the right nostril via a needle-less 
syringe. The number of sheep inoculated oronasally for each genotype was VVQQ, n=4; 
AVQQ, n=4; and AAQQ, n=4. Oronasally inoculated sheep were 3 months old at the time of 
inoculation. 
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Following inoculation, all sheep were housed for two weeks in a biosafety level 2 
facility. Subsequently, sheep were housed outside in pens at the National Animal Disease 
Center where they were fed a pelleted growth and alfalfa hay ration.  
The sheep were examined for signs of clinical scrapie on a daily basis. When 
unequivocal neurologic signs were noted, spontaneous intercurrent death occurred, or the 
experimental endpoint was reached, necropsy was performed on each animal.  
 
Sample collection 
The procedure for collection of samples was performed similar to other experiments 
(42). At necropsy, duplicate tissue samples were collected and stored in 10% buffered neutral 
formalin (globes in Bouin’s fixative) or frozen. Tissues collected included brain, spinal cord, 
pituitary, trigeminal ganglia, eyes, sciatic nerve, third eyelid, palatine tonsil, pharyngeal 
tonsil, lymph nodes (mesenteric, retropharyngeal, prescapular and popliteal), spleen, 
esophagus, forestomaches, intestines, rectal mucosa, thymus, liver, kidney, urinary bladder, 
pancreas, salivary gland, thyroid gland, adrenal gland, trachea, lung, turbinate, nasal planum, 
heart, tongue, and muscles (masseter, diaphragm, triceps brachii, biceps femoris, and psoas 
major). 
 
Microscopic and immunohistochemical evaluation 
For the evaluation of spongiform change, hematoxylin and eosin (HE) stained 
sections of cerebrum, brainstem and cerebellum from corresponding levels at the forebrain, 
basal nuclei, thalamus, midbrain, pons, medulla oblongata and obex were assessed by 
brightfield microscopy and scored as positive or negative.  
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To study the accumulation of PrPSc in tissue, bright-field microscopy was used in 
combination with immunohistochemistry (IHC) similar to previously described methods (25, 
41-43). Briefly, paraffin-embedded tissues were sectioned at their optimum thickness (brain 
4 µm, lymphoid 3 µm, other 5 µm). The presence of PrPSc and the pathologic phenotype 
(immunolabeling pattern and distribution) were evaluated by application of a cocktail 
containing two monoclonal antibodies (F89/160.1.5 and F99/97.6.1) each used at a 
concentration of 5 µg/ml utilizing an automated processor (Ventana Nexes, Ventana Medical 
Systems, Inc., Tucson, AZ). Immunohistochemical labeling patterns for PrPSc were 
evaluated. Explanations of the immunolabeling patterns of PrPSc have been published 
previously in detail (44-46).  
 
Western blot 
We evaluated the molecular characteristics of PrPSc using western blot detection on 
frozen sections of brain. Representative samples of each genotype and inoculation group 
were assessed and compared to selected TSEs of interest. Acetone precipitation was used for 
the blot comparing multiple TSE strains. The tissue volume equivalent (mg eq) loaded for 
scrapie, ovine TME, bovine TME, and L-BSE was 0.3 mg, 1.5 mg, 1.5 mg, and 1.5 mg, 
respectively. Acetone precipitation was performed as follows. Proteinase K treated brain 
homogenates were mixed with four volumes of -20 °C acetone and incubated 1.5 hours at 
−20 °C. The samples were pelleted (15,000 rcf for 10 min at 10 °C). The supernatant was 
discarded, and the pellet was resuspended in 1x LDS loading buffer containing 1 μL of β-
mercaptoethanol. Protein gel electrophoresis and subsequent immunoblotting procedures 
were performed as previously described (41) utilizing murine monoclonal antibodies Sha31 
(diluted to a final concentration of 0.15 µg/ml; Cayman Chemical Company, Ann Arbor, MI) 
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or P4 (diluted to a final concentration of 0.1 µg/ml; R-Biopharm, Inc., Marshall, MI), a 
biotinylated anti-mouse secondary antibody (diluted to a final concentration of 0.1 µg/ml; 
Biotinylated anti-mouse IgG, Amersham Biosciences, USA), and streptavidin conjugated to 
horseradish-peroxidase (diluted to a final concentration of 0.1 µg/ml; Streptavidin 
horseradish-peroxidase conjugate, Amersham Biosciences, USA). For detection and image 
acquisition, a chemiluminescent and chemifluorescent (HRP) substrate (Pierce ECL-Plus, 
ThermoFisher Scientific, Waltham, MA) was used in conjunction with a gel imaging system 
(G:BOX Chemi-XT4, Syngene, Frederick, MD).  
 
Enzyme immunoassay 
A commercially available enzyme immunoassay (HerdChek®, IDEXX Laboratories 
Inc., Westbrook, ME) was used to screen for the presence of PrPSc in brainstem at the level of 
the obex and the retropharyngeal lymph node. Assays were conducted according to kit 
instructions except that the samples were prepared as a 20% (w/v) tissue homogenate. Cut-
off numbers were determined with a negative control per kit instructions; values greater than 
the mean optical density (O.D.) of negative controls + 0.180 were considered positive for the 
purposes of screening samples. 
 
Transgenic mouse bioassays 
In order to rule out the possibility of undetectable infectious PrP within peripheral 
lymphoid tissue, we performed a bioassay with transgenic mice expressing ovine PRNP 
(Tg338). The RPLN of sheep with VVQQ or AAQQ genotypes were included in the 
bioassay (sheep 935 and 808, respectively). Thirty-two ovinized PRNP transgenic mice 
(Tg338) (47) were inoculated IP with 100 l of 1% w/v RPLN homogenate: eighteen with 
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VVQQ inoculum and fourteen with AAQQ inoculum. Separate groups of mice were also IC 
inoculated: seventeen with VVQQ inoculum and eighteen with AAQQ inoculum. Mice were 
monitored daily for the appearance of clinical signs. At the time of death or at the end of 
study, brains were tested for PrPSc by EIA. The attack rate was defined as the percentage of 
mice from an experimental group that had a positive EIA result. Incubation periods (IPs) 
were expressed as the mean number of days post-inoculation (days PI) for mice with positive 
EIA results. To determine the attack rate, mice dying from intercurrent disease or without 
clinical signs that survived 2 SD less than the mean IP of positive mice were excluded. 
 
Survival analyses 
Survival analyses for all experiments were performed using Graphpad Prism 7 
(GraphPad Software, San Diego, CA). Animals were censored only if they were negative and 
died from intercurrent disease before the experimental end-point.  
 
Definitions 
To analyze experimental data, the following definitions were utilized in agreement 
with previous reports (42). In the sheep experiment, the attack rate was defined as the 
percentage of animals from an experimental group that had detectable PrPSc in any tissue. 
Incubation period (IP) was defined as the amount of time that elapsed between inoculation 
and euthanasia at the onset of clinical signs.  
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Figure 1. Survival plot of sheep inoculated intracranially with the agent of TME. The 





Figure 2 A-D. Photomicrographs of brain regions from sheep that were inoculated 
intracranially with the agent of TME. Immunohistochemistry for PrPSc, monoclonal 
antibodies F89/160.1.5 and F99/97.6.1. A, PrPSc in the frontal neocortex from a sheep with 
an AAQR genotype. In this genotype there is diffuse particulate that is denser in neocortical 
layers IV and V. There are also prominent linear (arrow) and perineuronal (arrowhead) 
immunolabeling patterns. B, In the cerebrum from sheep with the AAQR genotype, there are 
vascular plaque-like accumulations (arrow) of PrPSc. The arrowhead indicates an area of 
coalescing particulate immunolabeling. C, Cerebellum from a sheep with an AVQQ 
genotype. In the granular layer there is particulate and intraglial immunolabeling, and in this 
image, linear type PrPSc (arrow) is evident in the molecular layer. The immunolabeling types 
present are typical of the VVQQ, AVQQ and AAQQ genotypes. D, Cerebellum from a sheep 
with the AAQR genotype. Overall there is less PrPSc immunolabeling. In the selected image 




Figure 3 A-B. Photomicrographs of PrPSc in peripheral tissues from sheep that were 
inoculated intracranially with the agent of TME. Immunohistochemistry for PrPSc, 
monoclonal antibodies F89/160.1.5 and F99/97.6.1. A, There is immunolabeling of PrPSc 
within the neuromuscular spindles of the masseter muscle of sheep #962 (VVQQ). B, There 




Figure 4. Western blots of brain samples from sheep that were inoculated intracranially with 
the bovine passaged TME agent (bTME). The blots were immunolabeled with either the 
Sha31 (top) or P4 (bottom) antibody. Sha31, The antibody Sha31 was used on brain 
homogenates from sheep with the AVQQ genotype. The banding patterns are similar to the 
inoculum (bTME). P4, The antibody P4 is immunoreactive with brain homogenates from 





Figure 5. Western blot comparing ovine TME (oTME) to other ruminant TSE types. The 
blot was immunolabeled with Sha31 anti-PrP antibody after acetone precipitation. Ovine 









Table 1. Experimental findings in sheep intracranially inoculated with TME agent.  















ENS   SE EIA 
962 VVQQ 32 + + - - - - M -   + + 
935 VVQQ 27 + + - - - - P -   + + 
811 VVQQ 32 + + - - - - M -   + + 
945 VVQQ 10a - NA - - - - - -   - - 
957 VVQQ 24 + + - - - - - -   + NA 
816 AVQQ 28 + + - - - - - -   + + 
818 AVQQ 61 + - - - - - - -   + + 
834 AVQQ 33 + + - - - - M -   + + 
841 AVQQ 31 + NA - - - - - -   + + 
808 AAQQ 26 + NA - - - NA NA -   + + 
815 AAQQ 53 + + - - - - - -   + + 
835 AAQQ 55 + + - - - - P +   + + 
936 AAQQ 26 + NA - - - - - -   + + 
833 AAQR 50 + - - - - - - -   + + 
951 AAQR 51 + - - - - - - -   + + 
955 AAQR 10a - - - - - - - -   - - 
970 AAQR 56 + - - - - - - -   + + 
PNRP = prion protein gene; MPI = months post-inoculation; PHT = pharyngeal tonsil; PAL = palatine tonsil; RPLN = 
retropharyngeal lymph node; RAMALT = Recto-anal mucosa associated lymphoid tissue; NMS = neuromuscular spindle; ENS = 
enteric nervous system; SE = spongiform encephalopathy; EIA = enzyme immunoassay; IC = intracranial; NA = not available; M = 
masseter; P = psoas major  






Table 2. Immunolabeling of PrPSc in tissue organized by genotype of intracranially inoculated Suffolk sheep. 
  
VVQQ     
#Positive / n 
AVQQ               
#Positive / n 
AAQQ            
#Positive / n 
AAQR           
#Positive / n 
Total number of sheep 4/5a 4/4 4/4 3/4a 
Excluding intercurrent disease 4/4 4/4 4/4 3/3 
Mean IP of negative sheep (days) 10     10 
Mean IP of positive sheep (days)  29 38 40 52 
Tissue         
Muscle     
     Masseter + + 0 0 
     Psoas major + 0 + 0 
Nervous: Non-CNS          
Retina + + + + 
Trigeminal ganglia + + + 0 
Sciatic nerve + 0 0 0 
Adrenal medulla + + 0 0 
Myenteric plexus (SI) 0 0 + 0 
CNS         
Cerebrum + + + + 
Cerebellum + + + + 
Brainstem + + + + 
Spinal cord + + + + 
Lymphoreticular 0 0 0 0 
Other         
Pituitary gland + + + + 
a Sheep culled or died from intercurrent disease; IP = incubation period; SI = small intestine 
+ = Positive; 0 = Negative 
90 
 GENERAL CONCLUSIONS 
General Discussion 
There are practical outcomes of TSE research. First, the origins of naturally occurring 
prion diseases can be studied by interspecies transmission experiments. Second, experimental 
TSE research is important to evaluating genetic contributions to prion disease susceptibility. 
In sheep there are numerous polymorphisms in the prion protein gene (PRNP). The work 
presented in the first half of this dissertation evaluates the susceptibility of sheep with a 
Q171K PRNP polymorphism to infection with classical scrapie. Previous research indicated 
that sheep with a QK171 genotype have a prolonged incubation period after intracranial 
inoculation [1]. We hypothesized that sheep with the K171 genotype would be relatively 
resistant to classical scrapie after a more natural route of inoculation. The results of this study 
demonstrate that sheep with the homozygous KK171 genotype are resistant to classical 
scrapie when inoculated with the same parameters that produced disease in less susceptible 
sheep genotypes (QK171 and QQ171). Our findings agree with recently published 
epidemiologic data that describes a low prevalence of natural scrapie in Greek dairy sheep 
with the QK171 haplotype and no cases in homozygous KK171 [2]. The results of our study 
have immediate effects on scrapie eradication programs worldwide and domestically. An 
increased prevalence of the K171 allele is documented in some flocks from Italy and Greece 
[2, 3], and there is a relatively higher incidence of K171 in some Mediterranean sheep 
breeds. The overall prevalence of the K171 allele in the United States is not known, but non-
random sampling on some farms indicates the K171 genotype is present in American 
Blackbelly, Black Hawaiian, Painted Desert, and Texas Dall sheep [D. Sutton and D. 
Norden, personal communication, unpublished data USDA APHIS, 2017]. Currently, the 
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United States scrapie eradication program uses selective breeding of genetically resistant 
genotypes to increase scrapie resistance at the individual and herd level. The documentation 
of KK171 resistance in the present research could be invaluable to a small producer with this 
genotype identified within their flock. 
Interspecies transmission experiments are critical for understanding the etiology and 
host ranges of naturally occurring TSEs. The second half of this work demonstrated that 
sheep are susceptible to the agent of transmissible mink encephalopathy via intracranial 
inoculation. Sheep were not susceptible to oronasal inoculation at the inoculation doses 
received. Given that sheep are permissible to infection via intracranial inoculation, it is 
possible that higher doses of infectious material or alternate inoculation routes, such as 
intralingual, could result in successful transmission. The purpose of intracranial inoculation 
is twofold: giving us a positive control and demonstrating the capability of host PrPSc 
amplification. Collectively, the absence of oral transmission and positive intracranial 
transmission demonstrates a high species barrier; sheep are relatively resistant to the TME 
agent.  
 Characterization of the disease phenotype in sheep with TME revealed at least two 
critical points. First, TME in sheep is distinct from classical scrapie in sheep. This signifies 
that scrapie is not likely to be the source of TME, at least not the Stetsonville, WI outbreak 
from where our TME sample was obtained. Second, if a case of TME in sheep occurred 
naturally, differentiation from scrapie via molecular glycosylation patterns and peripheral 
PrPSc distribution would be possible. In this experiment, we did not have material from L-
BSE infected sheep to compare directly to ovine TME; however, we observed that the 
peripheral distribution of PrPSc in our sheep was similar to published work on sheep with L-
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BSE [4]. This is interesting because research has previously indicated a similar phenotype 
between L-BSE and TME [5]. As originally proposed by Marsh et al. [6], the present 
research supports atypical BSE as the origin of TME in Stetsonville, WI as opposed to sheep 
scrapie. Interestingly, at the time Marsh made this observation, atypical BSE had not yet 
been described.  
 
Future Directions 
Future directions for this work include further testing the host ranges of TME and 
directly comparing TME strains to L-BSE in cattle. This work is ideally performed in a 
mouse model for two reasons. First, the incubation period of TSEs in mice is faster than 
livestock species. Secondly, the comparison of spongiform changes in mice permits the 
differentiation of TSE strains [7]. This research would give further credibility to the theory 
that TME originated from a cow with L-BSE. If we assume that this premise is true, the 
comparison of multiple interspecies transmissions of the TME agent is analogous to testing 
the permissiveness of L-BSE to cross species barriers. 
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